Influence of "Gerd" label on parents' decision to medicate infants

Pediatrics

Volumn 131, Issue 5, 2013, Pages 839-845

  Scherer, Laura D ^a,b   Zikmund Fisher, Brian J ^c,d   Fagerlin, Angela ^a,c,d   Tarini, Beth A ^c  

^a VA Center for Clinical Management Research   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Disease labels; Gastroesophageal reflux disease; GERD; Overtreatment

Indexed keywords

ADULT; ARTICLE; CHILD HEALTH CARE; DECISION MAKING; DRUG EFFICACY; DRUG USE; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; MALE; PARENTAL BEHAVIOR; PRIORITY JOURNAL; THERAPEUTIC ERROR;

EID: 84877018767     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2012-3070     Document Type: Article

References (16)

1. Hassall E. Over-prescription of acid-suppressing medications in infants: how it came about, why it's wrong, and what to do about it. J Pediatr. 2012;160(2):193-198
2. Nelson SP, Kothari S, Wu EQ, Beaulieu N, McHale JM, Dabbous OH. Pediatric gastroesophageal reflux disease and acid-related conditions: trends in incidence of diagnosis and acid suppression therapy. J Media Econ. 2009;12(4):348-355
3. Barron JJ, Tan H, Spalding J, Bakst AW, Singer J. Proton pump inhibitor utilization patterns in infants. J Pediatr Gastroenterol Nutr. 2007;45(4):421-427 (Pubitemid 350307159)
4. van der Pol RJ, Smits MJ, van Wijk MP, Omari TI, Tabbers MM, Benninga MA. Efficacy of proton-pump inhibitors in children with gastroesophageal reflux disease: a systematic review. Pediatrics. 2011;127(5):925-935
5. Orenstein SR, Hassall E, Furmaga-Jablonska W, Atkinson S, Raanan M. Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease. J Pediatr. 2009;154(4):514-520. e4
6. Orenstein SR, Hassall E. Pantoprazole for symptoms of infant GERD: the emperor has no clothes! J Pediatr Gastroenterol Nutr. 2010;51(4):537-, author reply 537-539
7. Higginbotham TW. Effectiveness and safety of proton pump inhibitors in infantile gastroesophageal reflux disease. Ann Pharmacother. 2010;44(3):572-576
8. Vandenplas Y, Rudolph CD, Di Lorenzo C, et al North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition; European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN). J Pediatr Gastroenterol Nutr. 2009;49(4):498-547
9. Cassel CK, Guest JA. Choosing wisely: helping physicians and patients make smart decisions about their care. JAMA. 2012;307(17):1801-1802
10. Moynihan R, Doust J, Henry D. Preventing overdiagnosis: how to stop harming the healthy. BMJ. 2012;344:e3502.
11. Welch HG, Schwartz L, Schwartz LM, Woloshin S. Overdiagnosed: Making People Sick in the Pursuit of Health. Beacon Press: Boston 2011
12. Hadler NM. The Last Well Person: How to Stay Well Despite the Health-Care System. McGill-Queen's University Press Montreal; 2004.
13. Haynes RB, Sackett DL, Taylor DW, Gibson ES, Johnson AL. Increased absenteeism from work after detection and labeling of hypertensive patients. N Engl J Med. 1978;299(14):741-744 (Pubitemid 9040909)
14. van Weel C. Does labelling and treatment for hypertension increase illness behaviour? Fam Pract. 1985;2(3):147-150
15. Carey WB, Sibinga MS. Avoiding pediatric pathogenesis in the management of acute minor illness. Pediatrics. 1972;49(4):553-562
16. Cabana MD, Rand CS, Powe NR, et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999;282(15):1458-1465 (Pubitemid 29493800)